Lamar Smith sold Linde plc Ordinary Shares (NASDAQ: LIN)
Lamar Smith (R-TX), a U.S. Representative, has disclosed 1 trade in Linde plc Ordinary Shares (LIN) since 2018, a single purchase.
The trade highlighted here is a sale: Lamar Smith sold Unknown of Linde plc Ordinary Shares (NASDAQ: LIN) on October 31, 2018. Since that trade, LIN is up +246.04% against the S&P 500 up +202.29%, an outperformance of +43.74%.
Data updated
Lamar Smith's LIN trades vs the price
LIN is up +246.04% since Lamar Smith sold on October 31, 2018, versus +202.29% for the S&P 500.
Performance since this trade
All Lamar Smith LIN trades
Lamar Smith & LIN trading FAQ
Is it legal for Lamar Smith to trade Linde plc Ordinary Shares (LIN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Linde plc Ordinary Shares (LIN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Lamar Smith sell LIN?
Lamar Smith disclosed a sale of Unknown of Linde plc Ordinary Shares (LIN) on October 31, 2018, according to public STOCK Act filings.
How has LIN performed since Lamar Smith's trade?
Since Lamar Smith sold LIN on October 31, 2018, the stock is up +246.04%, versus +202.29% for the S&P 500 over the same period, an outperformance of +43.74%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional LIN trades?
Quantellect tracks every disclosed congressional trade in Linde plc Ordinary Shares (LIN) on the Linde plc Ordinary Shares congressional trading page, which aggregates filings across all members of Congress.
Lamar Smith's LIN tradesAll congressional filings for Linde plc Ordinary SharesLamar Smith's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.